5 completed. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Immune Targeting Systems Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge Vaccine FP-01.1, Placebo, Virus Challenge - Influenza A | Phase 1 / Phase 2 | Completed | Immune Targeting Systems Ltd | 111 | 2014-01-01 | 2016-10-05 |
| Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers 1:1000 Live wild-type A/California/H1N1 2009, 1:100 Live wild-type A/California/H1N1 2009, 1:10 Live wild-type A/California/H1N1 2009 - Influenza A | Phase 1 | Completed | Immune Targeting Systems Ltd | 29 | 2013-06-01 | 2013-12-18 |
| Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults FP-01.1 + Placebo, FP-01.1 + TIV, FP-01.1-Adjuvant + Placebo - Influenza A | Phase 1 | Completed | Immune Targeting Systems Ltd | 120 | 2012-09-01 | 2013-07-29 |
| Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1) FP-01.1, FP-01.1-Adjuvant - Influenza A | Phase 1 | Completed | Immune Targeting Systems Ltd | 48 | 2012-01-01 | 2013-07-29 |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine FP-01.1, placebo - Influenza | Phase 1 | Completed | Immune Targeting Systems Ltd | 49 | 2010-08-01 | 2012-03-26 |
Influenza, Human (3) · Virus Diseases (2)
United Kingdom (2) · Australia (1) · Belgium (1)
Geert Leroux-Roels, Professor (1) · Joanne Marjason (1) · Steve Warrington, MD (1)